Efficacy and Safety of Pregabalin in Treatment of Neuropathic Pain in Patients With Idiopathic Small Fiber Neuropathy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Jul 2018
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 09 Jul 2018 Planned End Date changed from 1 Oct 2017 to 1 Oct 2018.
- 09 Jul 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.
- 09 Jul 2018 Status changed from recruiting to active, no longer recruiting.